GlassScriptPhysician profile
Taylor Boyd Strange
NPI 1023336633
$179,292.65
in general payments reported to CMS, 2019-2025
37 companies · $68K in 2025
The $68K reported for 2025 was more than what 99% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,796 · 2020: $1,584 · 2021: $8,145 · 2022: $39K · 2023: $6,925 · 2024: $52K · 2025: $68K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $65K · Food and Beverage: $51K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $11K · Travel and Lodging: $254 · Honoraria: $117 · Gift: $57.14 · Education: $5.18.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $64,775.00 |
| Food and Beverage | $50,834.10 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $11,150.25 |
| Travel and Lodging | $253.50 |
| Honoraria | $117.18 |
| Gift | $57.14 |
| Education | $5.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lensar, INC. | $95,690.87 | 2019-2025 | Lensar Laser System |
| Rxsight INC | $46,398.65 | 2021-2025 | Rxsight Contact Lens, Rxsight Injector Cartridge, Rxsight Light Delivery Device (Ldd) |
| Johnson & Johnson Surgical Vision, INC. | $19,387.92 | 2019-2025 | Tecnis Simplicity, Tecnis Iol, Veritas Vision System |
| Carl Zeiss Meditec USA, INC. | $3,528.01 | 2021-2025 | Callisto Eye, Cirrus Hd-Oct, Quatera 700 |
| Glaukos Corporation | $3,213.76 | 2019-2025 | Travoprost Intraocular Implant - Idose, Idosetr, Istent Infinite |
| Ocular Therapeutix, INC. | $1,654.48 | 2021-2025 | Dextenza |
| Beaver-Visitec International, INC. | $1,229.52 | 2019-2025 | |
| Abbvie INC. | $1,190.94 | 2022-2025 | Durysta, Lumigan, Vuity |
| Bausch & Lomb Americas INC. | $1,067.09 | 2022-2025 | Miebo, Vyzulta, Xiidra |
| Alcon Vision LLC | $987.18 | 2019-2025 | Wavelight Refractive Suite, Eysuvis, Hydrus Microstent |
| Biotissue Holdings INC. | $908.95 | 2020-2025 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $847.03 | 2019-2021 | |
| Allergan, INC. | $581.95 | 2019-2022 | |
| Sun Pharmaceutical Industries INC. | $347.34 | 2019-2025 | Cequa |
| Carl Zeiss Meditec, INC. | $342.06 | 2019-2020 |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tarsus Pharmaceuticals, INC. | $299.66 | 2024-2025 | Xdemvy |
| New World Medical,INC. | $279.46 | 2019 | |
| Harrow Eye, LLC | $149.91 | 2024-2025 | Vevye |
| Novartis Pharmaceuticals Corporation | $141.41 | 2019-2023 | |
| Kala Pharmaceuticals, INC. | $128.47 | 2020-2022 | |
| Ivantis, INC | $118.66 | 2019-2021 | |
| Sight Sciences, INC. | $104.39 | 2021-2024 | Omni Surgical System |
| Shire North American Group INC | $99.49 | 2019 | |
| Aerie Pharmaceuticals, INC. | $91.55 | 2020-2021 | |
| Topcon Healthcare, INC. | $90.01 | 2025 | |
| Dompe US, INC. | $69.64 | 2019-2025 | Oxervate |
| Oyster Point Pharma, INC. | $68.48 | 2022-2025 | Ryzumvi, Tyrvaya |
| Eyevance Pharmaceuticals LLC | $58.34 | 2019-2021 | |
| Omeros Corporation | $35.32 | 2021 | |
| Regeneron Healthcare Solutions, INC. | $31.13 | 2023 | Libtayo |
| Lumibird Medical INC. | $31.12 | 2025 | |
| Johnson & Johnson Vision Care, INC. | $24.78 | 2019 | |
| Thea Pharma INC. | $23.69 | 2024 | Iyuzeh |
| Staar Surgical Company | $22.78 | 2019 | |
| Tearlab Corp | $18.91 | 2023 | Tearlab Osmolarity System |
| Optos, INC. | $16.04 | 2021 | |
| Lombart Brothers, INC. | $13.66 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Taylor Strange listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.